Rheumatology Medical News about pseudogout

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure
Joint, Bone, Spine, 04/23/09

Announ N et al. - The authors describe the case of a 71-year-old man with recurrent pseudogout attacks affecting multiple joints. He had end-stage renal failure that contra-indicated the use of non-steroidal anti-inflammatory drugs and was resistant to therapy with glucocorticoids. Based on the recent findings that interleukin (IL)-1-beta is involved in crystal-induced inflammation, the patient received anakinra, a specific IL-1 inhibitor, in order to treat an acute attack of pseudogout.

<< Previous
Inhibition of the Mevalonate Pathway Rescues the...

Next >>
Validation of the KOFUS (Knee Osteoarthritis Flare-Ups Score)

Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica
Clinical Interventions in Aging, 10/01/09 Relevance Score: 83%